Single-chain vascular endothelial growth factor variant with antagonist activity

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Vascular endothelial growth factor (VEGF) is a key mitogen for endothelial cells, crucial for vascular system development.
• In adults, VEGF plays a role in pathological conditions like cancer by promoting angiogenesis.
• VEGF functions as a homodimer, activating its receptor through induced dimerization.

Purpose of the Study:

• To develop a more efficient method for creating modified VEGF variants.
• To investigate the feasibility of a single-chain approach for engineering homodimeric proteins.
• To create a VEGF antagonist by altering a single receptor-binding site.

Main Methods:

• Engineered a single-chain construct containing two VEGF monomers.
• Expressed and refolded the single-chain VEGF protein.
• Introduced monomer-specific mutations to create a variant with an altered receptor-binding site.

Main Results:

• The single-chain VEGF was functionally equivalent to the wild-type homodimer.
• The mutated single-chain variant acted as a specific antagonist, inhibiting VEGF-induced endothelial cell proliferation.
• Demonstrated the efficacy of the single-chain approach for targeted modification of homodimeric proteins.

Conclusions:

• A single-chain VEGF construct can be efficiently produced and is functionally active.
• Targeted mutagenesis of a single monomer within a single-chain construct allows for the creation of specific antagonists.
• The single-chain approach offers a viable strategy for engineering homodimeric proteins with altered functions, overcoming limitations of traditional heterodimerization methods.